CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Deep vein thrombosis - prevention for travellers - Management
Basis for recommendation
These recommendations are based on published guidelines, expert reviews and consensus documents [Kesteven, 2000; SIGN, 2002; Aerospace Medical Association Medical Guidelines Taskforce, 2003; Possick and Barry, 2004; British Committee for Standards in Haematology, 2005; Watson, 2005; Geerts et al, 2008; Sándor, 2008; Schobersberger et al, 2008; Watson and Chee, 2008; Silverman and Gendreau, 2009; Smith et al, 2010].
Use of graduated compression stockings and low molecular weight heparin (LMWH)
Seeking specialist advice
- Seeking specialist advice is recommended before prescribing LMWH because:
- The use of LMWH for the prevention of travel-related DVT is unlicensed.
- There is uncertainty regarding how LMWH should be used in the prevention of travel-related DVT [BMA, 2004].
- CKS found no clear guidance on the prescribing of LMWH (for example choice of preparation, dosage, time of administration, and duration of treatment) in high risk people, particularly if other risk factors are present (for example people with cancer).
© NHS Institute for Innovation and Improvement